Masayuki Fujioka Selected Research

Masayuki Fujioka Research Topics

Disease

11	Brain Ischemia (Cerebral Ischemia) 10/2012 - 02/2003
9	Infarction (Infarctions) 03/2016 - 03/2007
5	Stroke (Strokes) 10/2021 - 12/2002
4	Brain Injuries (Brain Injury) 10/2015 - 03/2008
3	Ischemic Stroke 10/2021 - 10/2015
3	Hemorrhage 03/2016 - 12/2011
3	Cerebral Infarction 09/2009 - 12/2002
2	Intracranial Vasospasm 12/2014 - 12/2011
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2013 - 12/2011
2	Ischemia 10/2012 - 12/2003
2	Transient Ischemic Attack 06/2011 - 12/2002
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2007 - 03/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2007 - 12/2003
1	Cerebral Hemorrhage 10/2015
1	Brain Diseases (Brain Disorder) 04/2015
1	Burns 01/2014
1	Pathologic Complete Response 11/2012
1	Neoplasm Metastasis (Metastasis) 11/2012
1	Neoplasms (Cancer) 11/2012
1	Inflammation (Inflammations) 10/2012
1	Encephalitis (Encephalitis, Rasmussen) 10/2012
1	Posterior Leukoencephalopathy Syndrome 02/2011
1	Myoma 02/2011
1	Brain Edema (Cerebral Edema) 10/2010
1	Glioma (Gliomas) 10/2010
1	Thrombosis (Thrombus) 02/2010
1	Atrophy 03/2008
1	Hypercholesterolemia 03/2007
1	Dementia (Dementias) 01/2006
1	Memory Disorders (Memory Loss) 01/2006
1	Cognitive Dysfunction 01/2006
1	Tremor (Tremors) 01/2006

Drug/Important Bio-Agent (IBA)

7	HMGB1 Protein (HMG1)IBA 03/2016 - 03/2008
4	CannabidiolIBA 09/2009 - 03/2007
4	Dronabinol (THC)FDA LinkGeneric 09/2007 - 01/2006
3	von Willebrand FactorIBA 10/2015 - 02/2010
2	SteroidsIBA 04/2015 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 03/2013 - 12/2011
2	Peroxidase (Myeloperoxidase)IBA 10/2012 - 12/2008
1	GTP Phosphohydrolases (GTPases)IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2015
1	ADAMTS13 ProteinIBA 10/2015
1	Shiga Toxin (Shigella Toxin)IBA 04/2015
1	ThrombomodulinIBA 04/2015
1	salicylhydroxamic acid (SHAM)IBA 12/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	ProcalcitoninIBA 03/2013
1	C-Reactive ProteinIBA 03/2013
1	Gemcitabine FDA Link 11/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2012
1	Glycoproteins (Glycoprotein)IBA 10/2012
1	AnticoagulantsIBA 06/2011
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2011
1	AcidsIBA 10/2010
1	SynaptophysinIBA 04/2010
1	fluorocitrateIBA 04/2010
1	Platelet Membrane GlycoproteinsIBA 02/2010
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	Minocycline (Cyclops)FDA LinkGeneric 03/2008
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2008
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2008
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 03/2007
1	CholesterolIBA 03/2007
1	Neuroprotective AgentsIBA 03/2007
1	OxotremorineIBA 01/2006
1	Muscarinic M1 ReceptorIBA 01/2006
1	Citalopram FDA LinkGeneric 01/2006
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2006
1	Scopolamine (Hyoscine)FDA Link 01/2006
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 12/2003
1	Amyloid (Amyloid Fibrils)IBA 12/2003
1	Superoxide DismutaseIBA 12/2003
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	ManganeseIBA 12/2003
1	Streptozocin (Streptozotocin)FDA Link 02/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2002
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2002

Therapy/Procedure

4	Therapeutics 10/2015 - 06/2011
1	Plasma Exchange 04/2015
1	Hemodiafiltration 04/2015
1	Radiofrequency Ablation 11/2012
1	Radiofrequency Therapy 11/2012
1	Uterine Artery Embolization 02/2011